Projects per year
- 1 Similar Profiles
Dive into details
Select a country/territory to view shared publications and projects
FWOSB45: Tumor-derived dendritic cell vaccination as novel approach for the prevention of cancer relapse
1/01/18 → 31/12/21
ANI297: Tumour-derived dendritic cell vaccination as a novel therapy to prevent metastasis and cancer relapse
1/01/22 → 31/12/22
In vivo pre-treatment of tumour-derived dendritic cells with anti-CD40 agonist mAb results in therapeutic responses in resistant tumour models when used as vaccination strategiesMurgaski, A., Clappaert, E., Kiss, M., Goyvaerts, C. & Laoui, D., 18 Oct 2019.
Research output: Unpublished contribution to conference › Poster
D'Huyvetter, M., Murgaski, A., Berus, D., Stangé, G., Clappaert, E. J., Arnouk, S., Pombo Antunes, A. R., Krasniqi, A., Lahoutte, T., Gonçalves, A., Vuylsteke, M., Raes, G., Devoogdt, N., Movahedi, K. & Van Ginderachter, J. A., 28 Nov 2019, In : Journal of Controlled Release. 314, p. 1-11 11 p.
Research output: Contribution to journal › Article9 Citations (Scopus)
Unleashing Tumour-Dendritic Cells to Fight Cancer by Tackling Their Three A's: Abundance, Activation and Antigen-DeliveryMurgaski, A., Bardet, P. M. R., Arnouk, S. M., Clappaert, E. J. & Laoui, D., 14 May 2019, In : Cancers. 11, 5, 16 p., 670.
Research output: Contribution to journal › Scientific reviewOpen Access7 Citations (Scopus)
Clappaert, E., Murgaski, A., Van Damme, H., Kiss, M. & Laoui, D., 8 Oct 2018, In : Frontiers in Immunology. 9, OCT, 2250.
Research output: Contribution to journal › Scientific reviewOpen Access22 Citations (Scopus)
Alexander Murgaski (Participant)12 Sep 2019 → 14 Sep 2019
Activity: Participating in or organising an event › Participation in conference
Alexander Murgaski (Speaker)1 Nov 2018 → 3 Nov 2018
Activity: Talk or presentation › Talk or presentation at a conference